News | June 06, 2026
Alembic Pharma receives USFDA approval for Haloperidol tablets
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
Approved product is therapeutically equivalent to Synthroid of AbbVie and is indicated for the treatment of congenital or acquired hypothyroidism
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
Darolutamide Tablets, 300 mg, had an estimated market size of US$ 3,155 million in the United States
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
Subscribe To Our Newsletter & Stay Updated
